NEW YORK (GenomeWeb) – ERS Genomics, a CRISPR/Cas9 commercialization vehicle, has licensed the genome editing technology to Swiss industrial biotech firm Evolva. Under the terms of the worldwide, non-exclusive licensing agreement, Evolva has the right to use the technology in engineering yeast and fungi for biomanufacturing purposes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.